Obagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience

Waldencast (NASDAQ: WALD) brand Obagi Medical has partnered with health optimization company Next Health to launch “The Skin Recharge Station,” a multi-city pop-up truck experience merging advanced skincare and longevity-focused wellness.

Rhea-AI Summary

Waldencast (NASDAQ: WALD) brand Obagi Medical has partnered with health optimization company Next Health to launch “The Skin Recharge Station,” a multi-city pop-up truck experience merging advanced skincare and longevity-focused wellness.

The May 2026 tour in California highlights NAD+ science, Obagi’s NU-GEN Cellular Renewal Serum, Aura skin analysis, and chances to win Next Health NAD+ shots and IV drips.

Argus May 14 session

-1.21% close to close Open Argus

Details

News Market Reaction – WALD

On May 14, the day this news came out, WALD closed 1.21% below the previous close.

Data tracked by StockTitan Argus for the May 14 session.

Market Context

This announcement centers on a marketing partnership between Obagi and Next Health, showcasing NU-GE...

Analysis

This announcement centers on a marketing partnership between Obagi and Next Health, showcasing NU-GEN™ Cellular Renewal Serum and highlighting NAD+-based skincare through a multi-city pop-up. It continues Obagi’s recent focus on innovation and longevity themes, following prior launches and collaborations. Historical news flow shows mixed market reactions to similar branding and product events, so investors may watch upcoming sales trends, additional product data, and future financial updates to assess how effectively such activations translate into growth.

Key Figures

Pop-up dates: May 14–15, 2026 Pop-up dates: May 16–17, 2026 Pop-up dates: May 23–24, 2026 +3 more

Pop-up dates

May 14–15, 2026

West Hollywood tour stop

Pop-up dates

May 16–17, 2026

Studio City tour stop

Pop-up dates

May 23–24, 2026

Newport Beach tour stop

Brand legacy

35+ years

Obagi Medical experience in skincare

Top brands cohort

Top 10

Among Top 10 Professional Skin Care Brands in U.S. in 2024

Footnote index

1

Reference to Kline’s 2024 Global Professional Skin Care Series

Historical Context

5 past events · Latest: Apr 30

5 events

1. Apr 30

   Product launch

   24h Move

   +16.6%

   Launch of new mineral sunscreen for sensitive and post-procedure skin.

2. Apr 28

   Regulatory update

   24h Move

   -2.1%

   SEC concluded investigation without intent to recommend enforcement action.

3. Mar 24

   Product launch

   24h Move

   -7.4%

   Launch of NU-GEN™ Cellular Renewal Serum with NAD+ and clinical claims.

4. Mar 19

   Clinical collaboration

   24h Move

   -8.3%

   Collaboration with ProMD in ALOHA Program for real-world MagIQ™ data.

5. Mar 13

   Earnings update

   24h Move

   +8.2%

   FY2025 results with positive EBITDA, asset sale, and lower net debt.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

nicotinamide adenine dinucleotide (nad+), nad+ iv drips, iv therapy

3 terms

nicotinamide adenine dinucleotide (nad+) medical

"the science behind Nicotinamide Adenine Dinucleotide (NAD+), and its role"

Nicotinamide adenine dinucleotide (NAD+) is a small molecule inside cells that helps convert food and nutrients into usable energy and supports many repair processes, acting like a battery charger for cellular machinery. Investors care because therapies, diagnostics and supplements that alter NAD+ levels are being studied for aging, metabolic and neurological conditions; positive clinical results or regulatory moves can change the prospects and valuation of companies working in those areas.

nad+ iv drips medical

"opportunities to win Next Health NAD+ Shots, NAD+ IV Drips, and take home"

NAD+ IV drips are intravenous infusions of nicotinamide adenine dinucleotide (NAD+), a naturally occurring compound involved in cellular energy and repair, given directly into the bloodstream—think of it like topping up a car battery to boost how cells run. They matter to investors because they represent a consumer-driven wellness and clinic service market that can generate recurring revenue, yet sales depend on limited clinical proof, safety concerns and regulatory oversight that can quickly affect demand and legal risk.

iv therapy medical

"At Next Health, we’ve delivered NAD+ systemically through IV therapy for years"

IV therapy is the medical practice of delivering fluids, medications, or nutrients directly into a vein through a small tube, so the substance reaches the bloodstream quickly like a highway shortcut compared with taking something by mouth. Investors care because IV treatments are often higher-margin services or products, can drive repeated clinic visits, and are subject to regulation, reimbursement rules and safety standards that affect revenue, costs and growth prospects.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

A multi-city pop-up introducing consumers to the future of skincare and longevity innovation 

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare innovation, the originator of medical-grade skincare and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), has partnered with the world’s most advanced and comprehensive brand of health optimization and longevity centers, Next Health, to create “The Skin Recharge Station,” an innovative limited-time pop-up truck merging advanced skincare with modern wellness.

The immersive experience introduces visitors to the concept of skin energy and provides education on the science behind Nicotinamide Adenine Dinucleotide (NAD+), and its role in supporting skin vitality. NAD+ is a vital coenzyme found in every cell that helps convert nutrients into energy and supports essential functions like cellular repair, metabolism, brain function, and healthy aging. Attendees will receive personalized Aura skin analyses, explore the benefits of Obagi’s latest launch, NU-GEN™ Cellular Renewal Serum, and engage in interactive touchpoints throughout the experience, including opportunities to win Next Health NAD+ Shots, NAD+ IV Drips, and take home product samples.

“We’re excited to partner with Next Health, a natural alignment of our shared focus on innovation in skincare and longevity,” said Justin Giouzepis, Chief Marketing Officer of Obagi Medical. “Together, we’re bringing an engaging, educational experience directly from the clinic to consumers, helping them better understand the science behind skin biology and how overall wellness impacts daily life.”

“NAD+ has long been a cornerstone molecule in longevity medicine because of its role in cellular energy production and DNA repair,” said Darshan Shah, MD, Founder & CEO of Next Health and Host of the EXTEND Podcast. “At Next Health, we’ve delivered NAD+ systemically through IV therapy for years, and now we’re thrilled to offer Obagi's proprietary topical application that supports those same cellular processes in the skin. It represents a powerful approach to healthy aging through a lens of true longevity.”

The tour will begin in West Hollywood (Sunset Blvd) from May 14–15, continue to Studio City (Sportsmen’s Lodge) from May 16–17, and conclude in Newport Beach (Fashion Island) from May 23–24. To learn more, visit here.

About Obagi Medical
Obagi Medical is an industry-leading, advanced skincare line rooted in research and skin biology, with a legacy of 35+ years of experience. Initially known for its leadership in the treatment of hyperpigmentation with the Obagi Nu-Derm® System, Obagi Medical products are designed to address a variety of skin concerns, including premature aging, photodamage, skin discoloration, acne, and sun damage. As the fastest-growing professional skincare brand in the U.S. in 2024,¹ Obagi Medical empowers individuals to achieve healthy, beautiful skin. More information about Obagi Medical is available on the brand's website, https://www.obagi.com.

About Waldencast plc
Founded by Michel Brousset and Hind Sebti, Waldencast’s ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast’s vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand’s distinct DNA. The first step in realizing its vision was the Business Combination. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: https://ir.waldencast.com.

About Next Health
Next Health is the world’s most advanced and comprehensive brand of health optimization and longevity centers, providing a personalized, data-driven approach to proactive healthcare. Founded in 2016 by renowned surgeon Dr. Darshan Shah and entrepreneur Kevin Peake, the company integrates preventative, lifestyle, functional, and longevity medicine into a seamless experience designed to help individuals live healthier for longer. Today, Next Health operates a growing global network of centers designed to optimize long-term health and performance.

Media Contact:
obagi@behrmancesa.com

Source: Waldencast plc

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/fa49dced-fa33-467c-9066-abc8a626e097

1.        Among the Top 10 Professional Skin Care Brands in the U.S., According to Kline’s 2024 Global Professional Skin Care Series (China, Europe and the U.S.).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Obagi and Next Health's “Skin Recharge Station” pop-up for WALD investors to know?

The “Skin Recharge Station” is a limited-time pop-up truck merging Obagi skincare with Next Health longevity services. According to Obagi, it offers Aura skin analysis, NU-GEN Cellular Renewal Serum education, and NAD+-focused wellness touchpoints to engage consumers directly in major California locations.

When and where will the Obagi and Next Health Skin Recharge Station tour run in May 2026?

The tour runs across three California stops in May 2026. According to Obagi, it visits West Hollywood May 14–15, Studio City May 16–17, and Newport Beach May 23–24, giving consumers multiple chances to experience the Skin Recharge Station pop-up.

How does NAD+ feature in the Obagi and Next Health Skin Recharge Station pop-up for WALD?

NAD+ is a central educational theme of the pop-up. According to Next Health, NAD+ supports cellular energy, repair, metabolism, brain function, and healthy aging, and the experience highlights both systemic IV delivery and Obagi’s proprietary topical approach for skin vitality.

What Obagi product is highlighted at the Skin Recharge Station, and what can visitors expect?

The tour showcases Obagi’s NU-GEN Cellular Renewal Serum. According to Obagi, visitors receive personalized Aura skin analyses, learn about NU-GEN’s role in supporting skin vitality, engage with interactive educational touchpoints, and can take home product samples from the pop-up experience.

Who are Obagi Medical and Next Health in the context of Waldencast (NASDAQ: WALD)?

Obagi Medical is a research-driven professional skincare brand within Waldencast, while Next Health operates health optimization and longevity centers. According to Waldencast, this partnership combines Obagi’s medical-grade skincare heritage with Next Health’s proactive, data-driven longevity approach in a consumer-facing activation.